| About Progenra | Scientific Interests | Technology Platform | Therapeutic Focus |
Progenra’s founders, staff, and Scientific Advisory Board have accumulated expertise in all aspects of ubiquitin and ubiquitin-like proteins (such as SUMO, ISG15, and Nedd8), including genetics, cell biology, biochemistry, and enzymology. Our experience in this area has enabled us to develop and validate assays for ubiquitin-related therapeutic targets and to screen for effectors of these targets.
web design by JOT Infomedia
